MX9703899A - Derivado de arilacrilamida. - Google Patents

Derivado de arilacrilamida.

Info

Publication number
MX9703899A
MX9703899A MX9703899A MX9703899A MX9703899A MX 9703899 A MX9703899 A MX 9703899A MX 9703899 A MX9703899 A MX 9703899A MX 9703899 A MX9703899 A MX 9703899A MX 9703899 A MX9703899 A MX 9703899A
Authority
MX
Mexico
Prior art keywords
arylacrylamide
derivatives
arylacrylamide derivatives
compounds
formula
Prior art date
Application number
MX9703899A
Other languages
English (en)
Other versions
MXPA97003899A (es
Inventor
Harry Ralph Howard
Barbara Eileen Segelstein
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9703899A publication Critical patent/MX9703899A/es
Publication of MXPA97003899A publication Critical patent/MXPA97003899A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Compuestos de formula: en lo que R1, R2, R3, R4, R5 y X se definen como en la descripcion. Estos compuestos son psicoterapéuticos utiles y potentes agonistas y antagonistas (5-HT1) de la serotonina.
MXPA/A/1997/003899A 1996-05-28 1997-05-27 Derivado de arilacrilamida MXPA97003899A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1858096P 1996-05-28 1996-05-28
US60/018,580 1996-05-28

Publications (2)

Publication Number Publication Date
MX9703899A true MX9703899A (es) 1998-06-30
MXPA97003899A MXPA97003899A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
EP0810220B1 (en) 2001-12-12
JPH1095765A (ja) 1998-04-14
PT810220E (pt) 2002-04-29
US6258953B1 (en) 2001-07-10
DE69708968T2 (de) 2002-04-25
DK0810220T3 (da) 2002-03-18
CA2206122C (en) 2002-03-05
CA2206122A1 (en) 1997-11-28
EP0810220A1 (en) 1997-12-03
JP3026948B2 (ja) 2000-03-27
DE69708968D1 (de) 2002-01-24
ATE210649T1 (de) 2001-12-15
ES2166046T3 (es) 2002-04-01

Similar Documents

Publication Publication Date Title
MXPA02000973A (es) Benzofurilpiperazinas y benzofurilhomopiperazinas: agonistas de serotonina.
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
MXPA02011977A (es) Herbicidas de piridina sustituidas.
MY118498A (en) Lactam derivatives
AP2001002103A0 (en) Substituted phenyl derivatives, their preparation and use.
YU40997A (sh) Novi oksadiazoli, postupci za njihovo pripremanje
MXPA03008754A (es) Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor.
MXPA05010652A (es) Pirazoles sustituidos.
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
YU39803A (sh) Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
ES2174298T3 (es) Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CA2206122A1 (en) Arylacrylamide derivatives
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
YU1302A (sh) Derivati aminotiazola i njihova primena kao liganada crf receptora
BG105710A (en) 5ht1 antagonists for antidepressant therapy
BG105539A (en) Eletriptan hydrobromide monohydrate
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
MXPA05010650A (es) Pirazoles sustituidos.
MX9700080A (es) Derivados de aril y heteroaril alcoxinaftaleno.
MX9603199A (es) Antagonistas de receptores a endotelina.
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
YU26001A (sh) Derivati ureidopiperidina kao selektivni antagonisti ljudskih nk3 receptora
MY131110A (en) Ergoline derivatives
YU23301A (sh) Postupak za dobijanje supstituisanih piridina
GEP19991792B (en) Substituted Propane-2-ol Derivatives, Process for Their Preparation, Pharmaceutical Composition and Process for Its Preparation

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees